IS6711A - Mótun fjölætta kínasa próteina - Google Patents
Mótun fjölætta kínasa próteinaInfo
- Publication number
- IS6711A IS6711A IS6711A IS6711A IS6711A IS 6711 A IS6711 A IS 6711A IS 6711 A IS6711 A IS 6711A IS 6711 A IS6711 A IS 6711A IS 6711 A IS6711 A IS 6711A
- Authority
- IS
- Iceland
- Prior art keywords
- polyunsaturated
- formation
- kinase proteins
- kinase
- proteins
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63705400A | 2000-08-11 | 2000-08-11 | |
| PCT/US2001/024822 WO2002014536A2 (en) | 2000-08-11 | 2001-08-08 | Odulating multiple lineage kinase proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS6711A true IS6711A (is) | 2003-02-10 |
Family
ID=24554347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS6711A IS6711A (is) | 2000-08-11 | 2003-02-10 | Mótun fjölætta kínasa próteina |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1309721A2 (pl) |
| JP (1) | JP2005503102A (pl) |
| CN (1) | CN1458979A (pl) |
| AU (2) | AU8317901A (pl) |
| BG (1) | BG107623A (pl) |
| BR (1) | BR0113266A (pl) |
| CA (1) | CA2419985A1 (pl) |
| CZ (1) | CZ2003680A3 (pl) |
| HR (1) | HRP20030162A2 (pl) |
| HU (1) | HUP0501110A3 (pl) |
| IL (1) | IL154311A0 (pl) |
| IS (1) | IS6711A (pl) |
| MX (1) | MXPA03001218A (pl) |
| NO (1) | NO20030658L (pl) |
| NZ (1) | NZ524034A (pl) |
| PL (1) | PL366248A1 (pl) |
| SK (1) | SK2692003A3 (pl) |
| WO (1) | WO2002014536A2 (pl) |
| ZA (1) | ZA200301109B (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
| EP1646372A2 (en) * | 2003-07-14 | 2006-04-19 | Decode Genetics EHF. | Methods of diagnosis and treatment for asthma based on haplotype association |
| US20060014165A1 (en) * | 2003-07-14 | 2006-01-19 | Decode Genetics Ehf. | Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association |
| US20060058250A1 (en) * | 2004-09-10 | 2006-03-16 | Cephalon, Inc. | Methods of treating proliferative skin diseases using carbazole derivatives |
| US20160082015A1 (en) * | 2013-04-18 | 2016-03-24 | President And Fellows Of Harvard College | Methods, compositions and kits for promoting motor neuron survival and treating and diagnosing neurodegenerative disorders |
| DK3425390T3 (da) * | 2016-11-25 | 2021-02-15 | Genuv Inc | Sammensætning til fremme af differentiering og beskyttelse af neurale stamceller og fremgangsmåde til induktion af neural regenerering ved anvendelse heraf |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
| US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
| JP2002523780A (ja) * | 1998-08-26 | 2002-07-30 | セフアロン・インコーポレーテツド | 多系統キナーゼタンパク質の調節 |
| US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
-
2001
- 2001-08-08 MX MXPA03001218A patent/MXPA03001218A/es not_active Application Discontinuation
- 2001-08-08 CN CN01814001A patent/CN1458979A/zh active Pending
- 2001-08-08 CZ CZ2003680A patent/CZ2003680A3/cs unknown
- 2001-08-08 PL PL01366248A patent/PL366248A1/pl not_active Application Discontinuation
- 2001-08-08 NZ NZ524034A patent/NZ524034A/en unknown
- 2001-08-08 JP JP2002519661A patent/JP2005503102A/ja active Pending
- 2001-08-08 CA CA002419985A patent/CA2419985A1/en not_active Abandoned
- 2001-08-08 SK SK269-2003A patent/SK2692003A3/sk not_active Application Discontinuation
- 2001-08-08 WO PCT/US2001/024822 patent/WO2002014536A2/en not_active Ceased
- 2001-08-08 IL IL15431101A patent/IL154311A0/xx unknown
- 2001-08-08 BR BR0113266-0A patent/BR0113266A/pt not_active IP Right Cessation
- 2001-08-08 EP EP01961958A patent/EP1309721A2/en not_active Withdrawn
- 2001-08-08 HU HU0501110A patent/HUP0501110A3/hu unknown
- 2001-08-08 AU AU8317901A patent/AU8317901A/xx active Pending
- 2001-08-08 HR HR20030162A patent/HRP20030162A2/hr not_active Application Discontinuation
- 2001-08-08 AU AU2001283179A patent/AU2001283179B2/en not_active Ceased
-
2003
- 2003-02-10 IS IS6711A patent/IS6711A/is unknown
- 2003-02-10 ZA ZA200301109A patent/ZA200301109B/en unknown
- 2003-02-10 NO NO20030658A patent/NO20030658L/no not_active Application Discontinuation
- 2003-03-10 BG BG107623A patent/BG107623A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03001218A (es) | 2003-05-27 |
| EP1309721A2 (en) | 2003-05-14 |
| IL154311A0 (en) | 2003-09-17 |
| HUP0501110A3 (en) | 2006-06-28 |
| AU8317901A (en) | 2002-02-25 |
| ZA200301109B (en) | 2004-07-20 |
| NO20030658L (no) | 2003-04-09 |
| CA2419985A1 (en) | 2002-02-21 |
| CZ2003680A3 (cs) | 2003-11-12 |
| BR0113266A (pt) | 2005-01-04 |
| NO20030658D0 (no) | 2003-02-10 |
| AU2001283179B2 (en) | 2006-07-13 |
| HRP20030162A2 (en) | 2005-12-31 |
| PL366248A1 (pl) | 2005-01-24 |
| CN1458979A (zh) | 2003-11-26 |
| WO2002014536A3 (en) | 2003-01-30 |
| JP2005503102A (ja) | 2005-02-03 |
| WO2002014536A9 (en) | 2003-12-18 |
| NZ524034A (en) | 2006-11-30 |
| WO2002014536A2 (en) | 2002-02-21 |
| HUP0501110A2 (en) | 2006-03-28 |
| SK2692003A3 (en) | 2003-08-05 |
| BG107623A (bg) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID29028A (id) | Pirolopirimidina sebagai penghambat protein kinase | |
| CY2007029I2 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| IS6968A (is) | Nýir týrósínkínasa tálmar | |
| DE60120219D1 (de) | Pyrazolverbindungen als protein-kinase-inhibitoren | |
| NO20014970L (no) | Cyklisk protein-tyrosin-kinase-inhibitor | |
| DE60129794D1 (de) | Pyrrol substituierte indolin-2-on protein kinase inhibitoren | |
| CY2014034I2 (el) | Υποκατεστημενες 3-κυανοκινολινες ως αναστολεις κινασων πρωτεϊνης τυροσινης | |
| AR028253A1 (es) | Inhibidores de la glucogeno fosforilasa | |
| EE200400003A (et) | Pürrolopürimidiinid kui valgukinaasi inhibiitorid | |
| EP1294513A4 (en) | COVALENT BIOCONJUGATION, RESTRICTION, PROTEINS | |
| ID30187A (id) | Dongkrak jenis pantagraf | |
| ATE255114T1 (de) | Tricyclische proteinkinasehemmer | |
| EP1259236A4 (en) | Tyrosine kinase inhibitors | |
| NO20024315L (no) | Ekspansjonsplugg | |
| DE50209300D1 (de) | Spreizdübel | |
| IS6711A (is) | Mótun fjölætta kínasa próteina | |
| ID30100A (id) | Suatu zat tambahan pakan | |
| DE60031450D1 (de) | Polymorph v von torasemid | |
| DE60007360T2 (de) | Amorphe modifikation von torasemid | |
| EA200200945A1 (ru) | Способ электронно-лучевой наплавки | |
| NO20035789L (no) | Ekspansjonsplugg | |
| UA3864S (uk) | Комплект туристських меблів | |
| UA4579S (uk) | Дозиметр-радіометр гамма-бета-випромінювань | |
| IT251699Y1 (it) | Struttura di lampada | |
| IT249794Y1 (it) | Struttura di riloga |